Pacira | PCRX - Pre Tax Profit

Stock Price
22.57
Daily Change
0.55 2.50%
Monthly
-2.80%
Yearly
-5.25%
Q1 Forecast
22.56

Pacira reported $9.52M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Assertio Holdings USD -2.88M 648K Sep/2024
Astellas Pharma JPY 133.96B 29.77B Dec/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Cara Therapeutics USD -4.91M 3.17M Mar/2025
Coherus Biosciences USD -46.35M 90.86M Dec/2025
Heron Therapeutics USD -2.95M 14.54M Dec/2025
Ironwood Pharmaceuticals USD 68.02M 30.2M Sep/2025
J&J USD 4.97B 2.53B Dec/2025
Ligand Pharmaceuticals USD 141.14M 102M Sep/2025
Nektar Therapeutics USD -37.05M 15.27M Sep/2024
Novo Nordisk DKK 33.8B 3.23B Jun/2025
Omeros USD -65.12M 21.27M Jun/2024
Pacira USD 9.52M 11.45M Sep/2025
Perrigo USD 22.4M 19.2M Sep/2025
Pfizer USD 3.33B 290M Sep/2025
Supernus Pharmaceuticals USD -1.91M 56.04M Dec/2025
Teva Pharmaceutical Industries USD 91M 555M Dec/2025
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025
Xoma USD 15.98M 24.58M Jun/2024
Zoetis USD 887M 15M Sep/2025